Literature DB >> 33933842

The immunomodulatory mechanism of dexmedetomidine.

Koichi Yuki1.   

Abstract

Dexmedetomidine has been increasingly introduced into the perioperative care of surgical patients. Because a subset of anesthetics/sedatives are immunomodulatory, it is critical to understand the role of dexmedetomidine in our host immune functions. Here we reviewed the role of dexmedetomidine in different immune cells. We also reviewed published clinical articles that described the role of dexmedetomidine in organ injury, cancer surgery, and infection. In animal studies, dexmedetomidine attenuated organ injury. In clinical studies, dexmedetomidine was associated with an improvement in outcomes in cardiac surgery and transplant surgery. However, there is a paucity in research examining how dexmedetomidine is associated with these outcomes. Further studies are needed to understand its clinical application from immunological standpoints.
Copyright © 2021 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Dexmedetomidine; Leukocyte; Outcome

Mesh:

Substances:

Year:  2021        PMID: 33933842      PMCID: PMC8324520          DOI: 10.1016/j.intimp.2021.107709

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   5.714


  90 in total

1.  Stress-induced redistribution of immune cells--from barracks to boulevards to battlefields: a tale of three hormones--Curt Richter Award winner.

Authors:  Firdaus S Dhabhar; William B Malarkey; Eric Neri; Bruce S McEwen
Journal:  Psychoneuroendocrinology       Date:  2012-06-22       Impact factor: 4.905

Review 2.  Stress-induced immune dysfunction: implications for health.

Authors:  Ronald Glaser; Janice K Kiecolt-Glaser
Journal:  Nat Rev Immunol       Date:  2005-03       Impact factor: 53.106

3.  The Immunological Genome Project: networks of gene expression in immune cells.

Authors:  Tracy S P Heng; Michio W Painter
Journal:  Nat Immunol       Date:  2008-10       Impact factor: 25.606

4.  Dexmedetomidine suppresses proinflammatory mediator production in human whole blood in vitro.

Authors:  Takashi Kawasaki; Chika Kawasaki; Masaya Ueki; Kohtaro Hamada; Kazutoshi Habe; Takeyoshi Sata
Journal:  J Trauma Acute Care Surg       Date:  2013-05       Impact factor: 3.313

5.  Ascending projections of the locus coeruleus in the rat. I. Axonal transport in central noradrenaline neurons.

Authors:  B E Jones; A E Halaris; M McIlhany; R Y Moore
Journal:  Brain Res       Date:  1977-05-20       Impact factor: 3.252

6.  Anesthetic technique and cancer outcomes: a meta-analysis of total intravenous versus volatile anesthesia.

Authors:  Andrea Yap; Maria A Lopez-Olivo; Julia Dubowitz; Jonathan Hiller; Bernhard Riedel
Journal:  Can J Anaesth       Date:  2019-03-04       Impact factor: 5.063

Review 7.  Past, Present, and Future of Regulatory T Cell Therapy in Transplantation and Autoimmunity.

Authors:  Marco Romano; Giorgia Fanelli; Caraugh Jane Albany; Giulio Giganti; Giovanna Lombardi
Journal:  Front Immunol       Date:  2019-01-31       Impact factor: 7.561

8.  Effects of dexmedetomidine on stress hormones in patients undergoing cardiac valve replacement: a randomized controlled trial.

Authors:  Hanhua Wu; Jinqing Tang; Jiamei Pan; Ming Han; Huijun Cai; Hong Zhang
Journal:  BMC Anesthesiol       Date:  2020-06-06       Impact factor: 2.217

Review 9.  Evaluating the Polarization of Tumor-Associated Macrophages Into M1 and M2 Phenotypes in Human Cancer Tissue: Technicalities and Challenges in Routine Clinical Practice.

Authors:  Sharmilla Devi Jayasingam; Marimuthu Citartan; Thean Hock Thang; Anani Aila Mat Zin; Kai Cheen Ang; Ewe Seng Ch'ng
Journal:  Front Oncol       Date:  2020-01-24       Impact factor: 6.244

10.  Activation of the sympathetic nervous system modulates neutrophil function.

Authors:  Alyce J Nicholls; Shu Wen Wen; Pam Hall; Michael J Hickey; Connie H Y Wong
Journal:  J Leukoc Biol       Date:  2017-12-21       Impact factor: 4.962

View more
  7 in total

Review 1.  Meta-analysis comparing dexmedetomidine versus standard of care for sedation in patients with sepsis.

Authors:  Basel Abdelazeem; Bilal Malik; Mohamed M G Mohamed; Pramod Savarapu; Sakiru Isa; Babikir Kheiri; Mustafa Hassan
Journal:  Proc (Bayl Univ Med Cent)       Date:  2021-11-08

Review 2.  The Role of miRNAs in Dexmedetomidine's Neuroprotective Effects against Brain Disorders.

Authors:  Codrin-Constantin Burlacu; Maria-Adriana Neag; Andrei-Otto Mitre; Alexandru-Constantin Sirbu; Andrei-Vlad Badulescu; Anca-Dana Buzoianu
Journal:  Int J Mol Sci       Date:  2022-05-13       Impact factor: 6.208

Review 3.  Role of adrenergic receptor signalling in neuroimmune communication.

Authors:  Sushanta Chhatar; Girdhari Lal
Journal:  Curr Res Immunol       Date:  2021-11-25

Review 4.  The Role of Dexmedetomidine in Tumor-Progressive Factors in the Perioperative Period and Cancer Recurrence: A Narrative Review.

Authors:  Qiang Cai; Guoqing Liu; Linsheng Huang; Yuting Guan; Huixia Wei; Zhiqian Dou; Dexi Liu; Yang Hu; Meiling Gao
Journal:  Drug Des Devel Ther       Date:  2022-07-06       Impact factor: 4.319

5.  Impact of intravenous dexmedetomidine on gastrointestinal function recovery after laparoscopic hysteromyomectomy: a randomized clinical trial.

Authors:  Yu Wu; Zenghua Cai; Lishuang Liu; Jinbao Wang; Yanli Li; Yuling Kang; Ni An
Journal:  Sci Rep       Date:  2022-08-27       Impact factor: 4.996

6.  Dexmedetomidine reduces myocardial ischemia-reperfusion injury in young mice through MIF/AMPK/GLUT4 axis.

Authors:  Siyu Chen; Aimei Li; Jianjiang Wu; Yidan Huang; Tiantian Zou; Taiwangu Tailaiti; Jiang Wang
Journal:  BMC Anesthesiol       Date:  2022-09-14       Impact factor: 2.376

7.  Effect of dexmedetomidine on postoperative systemic inflammation and recovery in patients undergoing digest tract cancer surgery: A meta-analysis of randomized controlled trials.

Authors:  Wenjie Xu; Yuxiang Zheng; Zizheng Suo; Kailun Fei; Yalong Wang; Chao Liu; Shuai Li; Mingzhu Zhang; Yefan Zhang; Zhaoxu Zheng; Cheng Ni; Hui Zheng
Journal:  Front Oncol       Date:  2022-09-14       Impact factor: 5.738

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.